Market News / Story
Viatris (VTRS) Agrees to Acquire Pacira BioSciences
·
Viatris said it agreed to acquire Pacira BioSciences to advance its innovative medicines strategy and expand in non‑opioid pain therapies. Material Details #DetailAI Analyst View1Agrees to acquire PaciraM&A can alter revenue mix, margins, and leverage; deal terms will drive valuation impact.2Targets non‑opioid pain segmentAdds exposure to a growing therapeutic area, potentially diversifying revenue.3Fits innovative medicines pushSignals continued shift from legacy…